[Treatment perspectives for patients not eligible for therapies for cystic fibrosis].
Emmanuelle Bardin(Centre National de la Recherche Scientifique), Isabelle Sermet-Gaudelus(Hôpital Necker-Enfants Malades), Iwona Pranke(Centre National de la Recherche Scientifique), Marie Giorgi(Hôpital Necker-Enfants Malades), Mairead Kelly-Aubert(Hôpital Necker-Enfants Malades)
PubMed
October 1, 2025
Cited by 0
Related Papers
<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
|Expert Review of Respiratory Medicine|2016|170
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
|FEMS Microbiology Letters|2017|107
Modulators of CFTR. Updates on clinical development and future directions
|European Journal of Medicinal Chemistry|2021|67